BIOPORTO A/S financials
BIOPORTO A/S
5299004SWFL5JAN4W830 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | DKK 40.3M | DKK 36.2M |
| Cost of sales | DKK 9.9M | DKK 11.7M |
| Gross profit | DKK 30.4M | DKK 24.5M |
| Administrative expenses | DKK 38.9M | DKK 36.2M |
| Operating profit (EBIT) | -DKK 86.1M | -DKK 75.5M |
| Finance costs | DKK 2.1M | DKK 834.0K |
| Profit before tax | -DKK 87.6M | -DKK 73.7M |
| Income tax expense | -DKK 5.5M | -DKK 5.5M |
| Profit for the year | -DKK 82.1M | -DKK 68.2M |
| Total comprehensive income | -DKK 79.8M | -DKK 69.5M |
| Per share | ||
| Basic EPS | DKK -0.00 | DKK -0.00 |
| Free cash flow / share | DKK -0.00 | DKK -0.00 |
| Cash flow statement | ||
| Cash generated from operations | -DKK 82.7M | -DKK 89.8M |
| Net cash from operating activities | -DKK 77.1M | -DKK 83.6M |
| Net cash from investing activities | DKK 1.3M | DKK 1.2M |
| Purchase of PP&E (capex) | DKK 0 | DKK 350.0K |
| Net cash from financing activities | DKK 71.9M | DKK 75.5M |
| Lease liability payments | DKK 3.8M | DKK 2.5M |
| Net change in cash | -DKK 3.9M | -DKK 6.9M |
| Balance sheet | ||
| Total assets | DKK 93.2M | DKK 96.0M |
| Non-current assets | DKK 8.2M | DKK 12.1M |
| Property, plant & equipment | DKK 1.5M | DKK 2.1M |
| Right-of-use assets | DKK 4.8M | DKK 6.6M |
| Current assets | DKK 85.0M | DKK 83.9M |
| Inventories | DKK 9.2M | DKK 4.6M |
| Trade & other receivables | DKK 9.4M | DKK 8.2M |
| Cash & equivalents | DKK 54.9M | DKK 59.7M |
| Total equity | DKK 63.0M | DKK 67.8M |
| Non-current liabilities | DKK 4.0M | DKK 7.8M |
| Lease liabilities (non-current) | DKK 4.0M | DKK 7.8M |
| Current liabilities | DKK 26.1M | DKK 20.4M |
| Lease liabilities (current) | DKK 3.5M | DKK 3.3M |
| Derived metrics | ||
| Free cash flow | -DKK 77.1M | -DKK 83.9M |
| Operating margin | -213.7% | -208.2% |
| Net margin | -203.8% | -188.3% |
| Return on equity | -130.3% | -100.7% |
| Cash conversion ratio | 0.94× | 1.22× |
| Capex coverage | — | -238.81× |
| Other reported items | ||
| Accruals Classified As Current | DKK 8.6M | DKK 5.7M |
| Adjustments For Decrease Increase In Inventories | -DKK 4.9M | -DKK 864.0K |
| Adjustments For Decrease Increase In Trade Account Receivable | -DKK 1.2M | -DKK 5.8M |
| Adjustments For Depreciation and Amortisation Expense | DKK 2.5M | DKK 2.4M |
| Adjustments For Increase Decrease In Trade Account Payable | DKK 2.7M | -DKK 6.8M |
| Adjustments For Sharebased Payments | -DKK 637.0K | -DKK 875.0K |
| Current Finance Lease Receivables | DKK 1.1M | DKK 1.2M |
| Current Prepayments | DKK 2.3M | DKK 2.4M |
| Current Tax Assets Current | DKK 6.8M | DKK 6.4M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -DKK 919.0K | DKK 192.0K |
| Equity and Liabilities | DKK 93.2M | DKK 96.0M |
| Finance Costs Paid Classified As Operating Activities | DKK 205.0K | DKK 381.0K |
| Finance Income | DKK 511.0K | DKK 2.5M |
| Finance Income Received Classified As Operating Activities | DKK 347.0K | DKK 1.6M |
| Finance Lease Receivables | DKK 393.0K | DKK 1.7M |
| Financial Assets | DKK 1.7M | DKK 3.1M |
| Gains Losses On Exchange Differences On Translation Net of Tax | DKK 2.3M | -DKK 1.3M |
| Income Taxes Refund Classified As Operating Activities | DKK 5.4M | DKK 4.9M |
| Increase Decrease Through Sharebased Payment Transactions | -DKK 637.0K | -DKK 875.0K |
| Intangible Assets Other Than Goodwill | DKK 138.0K | DKK 276.0K |
| Issue of Equity | DKK 76.9M | DKK 81.4M |
| Issued Capital | DKK 495.1M | DKK 429.7M |
| Liabilities | DKK 30.2M | DKK 28.2M |
| Other Adjustments For Noncash Items | DKK 2.2M | -DKK 1.4M |
| Other Comprehensive Income | DKK 2.3M | -DKK 1.3M |
| Other Current Receivables | DKK 1.2M | DKK 1.4M |
| Payments For Share Issue Costs | DKK 1.1M | DKK 3.4M |
| Proceeds From Issuing Shares | DKK 76.9M | DKK 81.4M |
| Research and Development Expense | DKK 50.5M | DKK 33.5M |
| Reserve of Exchange Differences On Translation | DKK 1.2M | -DKK 1.1M |
| Sales and Marketing Expense | DKK 27.2M | DKK 30.2M |
| Share Issue Related Cost | DKK 1.1M | DKK 3.4M |
| Trade and Other Current Payables To Trade Suppliers | DKK 14.0M | DKK 11.3M |
Every line item above is a fact tagged in BIOPORTO A/S's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (DKK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.